Remove Advocacy Remove Cannabinoids Remove Clinical Trials Remove Collective
article thumbnail

These Patient Advocacy Groups Are Working Together to Expand the Scope of Cannabis Research

Veriheal

Dedicated to “redefining what’s possible,” the 501(c)(3) organization has provided 1:1 support and resources to over 69,000 clients as they navigated plant-powered cannabinoid therapy. Cannabis Advocacy With a Digital Twist. RoC also works to increase patients’ access to medical cannabis by helping U.S.

article thumbnail

Veriheal’s Innovation in Cannabis Scholarship 2020 Winners

Veriheal

However, social and economic barriers like racial stereotypes and lack of access to care centers have historically barred Hispanic community members from seeking medical cannabis and participating in clinical trials. Maha was the founder and president of UCLA’s first registered cannabis student group, Cannaclub.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

New Study: Demographic and policy-based differences in behaviors and attitudes towards driving after marijuana use: an analysis of the 2013–2017 Traffic Safety Culture Index

Cannabis Law Report

An alternative approach to study relationships between marijuana policies and driving after marijuana use is to use surveys that collect information on self-reported behaviors and attitudes. Cannabis Cannabinoid Res. 9-tetrahydrocannabinol on driving performance: a randomized clinical trial. Article Google Scholar.

Policy 59
article thumbnail

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

The recreational use of cannabis is well known and attributed to its power as a psychotropic plant, specifically due to the cannabinoid tetrahydrocannabinol (THC). Data collection. These were news stories focusing on the use of cannabinoids for chronic cancer pain or inhibiting tumour growth, and mental illness. Discussion.

article thumbnail

Psychedelic Invest’s 100 Most Influential People in Psychedelics List

Cannabis Law Report

Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. Healing Advocacy Fund. Rick Doblin, Ph.D, in/rickdoblin/ [link]. in/andrew-chadeayne-989b751/ [link]. Sam Chapman. Kevin O’Leary.